Chemical Risk Factors of Primary Liver Cancer: An Update
Adam Barsouk,Krishna Chaitanya Thandra,Kalyan Saginala,Prashanth Rawla,Alexander Barsouk
DOI: https://doi.org/10.2147/HMER.S278070
2022-05-25
Hepatic Medicine: Evidence and Research
Abstract:Adam Barsouk, 1 Krishna Chaitanya Thandra, 2 Kalyan Saginala, 3 Prashanth Rawla, 4 Alexander Barsouk 5 1 Sidney Kimmel Cancer Center, Jefferson University, Philadelphia, PA 19107, USA; 2 Department of Pulmonary and Critical Care Medicine, Sentara Virginia Beach General Hospital, Virginia Beach, VA, USA; 3 Plains Regional Medical Group Internal Medicine, Clovis, NM 88101, USA; 4 Department of Medicine, Sovah Health, Martinsville, VA 24112, USA; 5 Hematologist-Oncologist, Allegheny Health Network, Pittsburgh, PA 15212, USA Correspondence: Prashanth Rawla Department of Internal Medicine/Hospitalist, SOVAH Health, 320 Hospital Dr, Martinsville, VA 24115, USA Tel +1 336-701-2285 Email Primary liver cancer has the sixth highest incidence and fourth highest cancer mortality worldwide. Hepatitis B is the leading cause of liver cancer, though its incidence is decreasing with vaccination. Alcohol is the leading cause of liver transplant, cirrhosis, and cancer in the developed world, and is projected to surpass hepatitis B as the leading hepatic cancer etiology worldwide. Tobacco smoking has shown a positive association with liver cancer in a majority of studies, though not all. Aflatoxin, a mycotoxin produced by Aspergillus , is estimated to account for 3– 20% of global liver cancer cases, 40% of which occur in sub-Saharan Africa. These statistics are confounded by the prevalence of hepatitis B, which may have a synergistic effect on hepatic carcinogenesis. Aflatoxin is ingested and likely inhaled from agricultural products, placing farmers, food processors, and textile workers in developing nations at risk. Vinyl-chloride is used in the production of PVC plastics and causes rare liver angiosarcoma, hepatocellular carcinoma, and other neoplasms. Arsenic and cadmium are naturally-occurring, hepatocarcinogenic metals with high occupational exposure in industries involving coal, metals, plastics, and batteries. Millions of laborers in waste-disposal and manufacturing are exposed to organic solvents and N-nitrosamines, which vary from carcinogenic (group 1) to possibly carcinogenic (group 2B) in their IARC designation. Insecticide DDT is possibly hepatocarcinogenic (group 2B), though continues to be used for malaria control in the developing world. While suggested by case reports, anabolic steroids and oral contraceptives have not been shown to increase liver cancer risk in large studies. Keywords: chemical agents, hepatocellular carcinoma, occupational exposure, aflatoxin, pesticides A Letter to the Editor has been published for this article. A Response to Letter has been published for this article. Cancer of the liver is the sixth most commonly diagnosed cancer and the fourth most common cause of cancer death worldwide, according to the most recent GLOBOCAN estimates. There were an estimated 841,000 new cases of liver cancer in 2018, and the neoplasm was responsible for an estimated 782,000 mortalities. 1 In the United States, liver cancer is the fifth leading cause of cancer death, responsible for 30,160 deaths in 2020, which accounts for 5.0% of all cancer deaths. Liver cancer is over twice as likely in men. 2 Primary liver cancer is mostly composed of hepatocellular carcinoma (HCC), which accounts for 75–85% of cases, and intrahepatic cholangiocarcinoma (neoplasm of the bile ducts), which accounts for 10–15% of cases. Around the world, chronic viral hepatitis, namely hepatitis B and C, is currently the leading cause of HCC. However, rising rates of global alcohol consumption and obesity are predicted to surpass viral hepatitis as the most common etiologies of HCC. Between 1990 and 2015, global liver cancer incidence has increased by 75%. Liver cancer incidence due to hepatitis B decreased during this period (when adjusted for population growth) thanks to vaccinations, while liver cancer due to hepatitis C and alcohol increased by 114% and 109%, respectively. 3 In the United States, liver cancer incidence has more than tripled from 2.6/100,000 new cases in 1975 to 8.7/100,000 in 2017. Lifestyle changes such as growing rates of obesity and injectable-drug abuse (associated with HCV), as well as immigration of large populations from regions with high chronic HBV prevalence, has contributed to the growing US HCC incidence. Mortality has also increased, albeit less rapidly due to improved survival rates, from 2.8/100,000 to 6.7/100,000 in the same time frame. The 5-year survival rate of the disease was a dismal 19.6% in 2016, still an improvement from 3.1% in 1975. Limited early detection contributes to poor survival, as the 5-year survival rate for metastatic disease is only 2.5%. 2 With low survival rates and increasing global inc -Abstract Truncated-